Sidley’s 2023 Global Life Sciences Trendspotting Report maps out seven key trends in the life sciences industry globally, and identifies some regional trends in the U.S., China, and Europe which are likely to have global ramifications during the coming year.

The industry is experiencing increased regulatory and financial pressures in many areas. However, the current economic environment is also generating competitive advantages for the companies most adept at structuring their global product life cycles, supply chains, and business plans across the regions and countries which are still seeking to attract investment.

These trends have been identified by pooling the vast collective experience of Sidley’s pioneering and sophisticated Global Life Sciences lawyers who are already advising on how to navigate the challenges raised in this report.

Sidley’s Global Life Sciences team comprises over 200 lawyers advising companies on the full scope of regulatory, compliance and enforcement, litigation, and transactions for some of the most precedent setting innovations in every sector of the dynamic life sciences industry. 

With a Threatened Recession, Life Sciences Companies and Healthcare Providers Consider Alternative Liquidity Options

Digital Health and Medical Artificial Intelligence Innovation Will Continue at a Breakneck Pace, Requiring a Robust Global Regulatory, Data, and Reimbursement Strategy

Increasingly, Life Sciences and Healthcare Providers Proactively Consider Offensive Challenges to U.S. Government Agencies

Life Sciences and Healthcare Enforcement and Litigation Activity is Increasing

Shifting Regulatory Opportunities and Pitfalls Suggest Biotech Companies Should Pressure-Test Initial Development and Launch Destinations

Environmental, Social, and Governance (ESG) Programs will be Subject to Increased Scrutiny

New Privacy and Cyber Laws in U.S., Europe, and China Add Complexity While Enforcement Against Life Sciences Companies Is Rising